No abstract available
MeSH terms
-
Aged
-
Cohort Studies
-
Female
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Incidence
-
Inpatients / statistics & numerical data*
-
Male
-
Prognosis
-
Retrospective Studies
-
Risk Assessment / methods*
-
Risk Factors
-
Stroke / drug therapy*
-
Stroke / mortality*
-
Survival Analysis
-
Survival Rate
-
Thrombolytic Therapy / statistics & numerical data*
-
Tissue Plasminogen Activator / therapeutic use*
-
Treatment Outcome
-
United States
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator